CDK5RAP3 Inhibition by Hypoxia Activates P38MAPK to Facilitate Angiogenesis

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• CDK5RAP3 acts as a tumor suppressor by inhibiting cell cycle kinases (Chk1, Chk2) and activating p53, crucial for apoptosis.
• CDK5RAP3 also modulates p38 MAPK pathway activity, impacting cellular stress responses.

Purpose of the Study:

• To investigate the antiangiogenic potential of CDK5RAP3.
• To elucidate the molecular mechanisms of CDK5RAP3 in regulating angiogenesis in human umbilical vein endothelial cells (HUVECs) under hypoxia.

Main Methods:

• HUVECs were subjected to hypoxic conditions (2% O2) to induce angiogenesis.
• Vascular endothelial growth factor (VEGF) was used to stimulate angiogenesis.
• Levels of CDK5RAP3, p38MAPK phosphorylation, and VEGF secretion were measured.
• Cell proliferation, migration, and tube formation assays were performed using hypoxic conditioned medium (HCM).

Main Results:

• Hypoxic conditions led to a time-dependent decrease in CDK5RAP3 levels in HUVECs.
• Reduced CDK5RAP3 correlated with increased p38MAPK phosphorylation and activation.
• Moderate hypoxia significantly increased VEGF secretion.
• HCM enhanced HUVEC proliferation, migration, and tube formation.

Conclusions:

• Moderate hypoxia promotes angiogenesis by inhibiting CDK5RAP3 expression in endothelial cells.
• CDK5RAP3 plays a critical role in vascular regeneration, with its downregulation enhancing VEGF synthesis and endothelial cell functions.
• CDK5RAP3 demonstrates potential as an antiangiogenic agent for conditions involving aberrant angiogenesis, such as cancer, ischemic diseases, and wound healing.